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Abstract
OBJECTIVE: To observe the effects of different dos-
es of Wenxiao II Decoction on the expression of
monocyte chemoattractant protein-1 (MCP-1) and
vascular cell adhesion molecule-1 (VCAM-1) in an
experimental model of atherosclerosis in rabbits
and to explore the mechanism by which it allevi-
ates atherosclerosis.
METHODS: Sixty 3-4 month-old New Zealand rab-
bits of both sexes were randomly divided into six
groups: simvastain; model; blank; and high-dose,
mid-dose, and low-dose Wenxiao II Decoction
groups. Except for those in the blank group, all rab-
bits were fed a high-cholesterol diet. Carotid ath-
erosclerosis was established by balloon-induced in-
jury to the endothelium of the carotid artery in con-
junction with consumption of a high-cholesterol di-
et. After 8 weeks, all rabbits were killed to evaluate
the expression of MCP-1 and VCAM-1 by immuno-
histochemical staining.
RESULTS: Expressions of MCP-1 and VCAM-1 were
significantly decreased in all groups except the
blank group compared with the model group (P<
0.05). When compared with the simvastain group
only variation of MCP-1 expression in low-dose
group was not appreciable, and the differences
were indistinct (P<0.05). When comparing among
Wenxiao II Decoction groups, MCP-1 expression in
the mid- and high-dose groups was significantly
lower than that seen in the low-dose group (P<
0.01), but there were no differences among three
dosage groups with respect to VCAM-1 expression
(P>0.05).
CONCLUSION: These data suggested that high,
mid, and low doses of Wenxiao II Decoction can in-
hibit the expression of MCP-1 and VCAM-1, which
may prevent the formation of or stabilize athero-
sclerotic plaques. There may be a direct relation-
ship between the dosage of Wenxiao II Decoction
and its therapeutic efficacy.
© 2012 JTCM. All rights reserved.
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INTRODUCTION
Atherosclerosis is a chronic inflammatory process [1]. It
involves in the formation, progression, rupture, and
thrombosis of atherosclerotic plaques[2-4]. Monocyte
chemoattractant protein-1 (MCP-1), vascular cell adhe-
sion molecule-1 (VCAM-1) and other inflammatory
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cytokines have important roles in the development of
atherosclerosis[5-6]. They can aggravate inflammation,
destabilize plaques, attenuate fibrin caps, and eventual-
ly rupture plaques, causing thrombosis. Recent studies
have shown that plaque rupture and subsequent intra-
luminal thrombosis is the most common cause of acute
coronary syndrome. Early prevention of plaque rup-
ture might be an effective way to reduce the risk of this
catastrophic life-threatening event. Unfortunately, an
ideal drug for stabilizing vulnerable plaques has not
been developed. Therefore, finding an effective means
of interfering with the production of these inflammato-
ry cytokines is of considerable medical significance. Ex-
ploration of new drugs with high efficacy and few side
effects for stabilizing vulnerable plaques is clearly war-
ranted. Furthermore, our previous experimental results
indicated that Wenxiao cereal recipes could inhibit the
expression of inflammatory cytokines such as fibrino-
gen, C-reactive protein, tumor necrosis factor-α
(TNF-α), and intercellular adhesion molecule-1
(ICAM-1). Wenxiao cereal recipes were also effective
for the regulation of blood lipids[7-8]. The present study
was carried out to test the effects of different doses of
Wenxiao II Decoction on the expression of MCP-1
and VCAM-1 in atherosclerotic rabbits, and to develop
a better understanding of the mechanism underlying
its clinical efficacy.
MATERIALS ANDMETHODS
Experimental animals
Sixty 3-4-month-old New Zealand rabbits of both sex-
es (2.2-2.5 kg) were purchased from the Shanghai
Shengwang Experimental Animal Breeding Co. Ltd.
(Shanghai, China). Rabbits were kept in the Experi-
mental Animal Center of the Sixth People's Hospital
(affiliated to Shanghai Jiaotong University, Shanghai,
China) for 1 week under the following conditions:
Room temperature was maintained at 22-24°C and the
relative humidity was 50%. Rabbits were exposed to a
light-dark cycle with illumination from 7 am to 5 pm.
All rabbits had free access to food and water before ex-
perimentation.
Drugs
Wenxiao II Decoction was prepared by Tianyin Phar-
maceutical (Chengdu, China; production series num-
ber, 20090809). It was composed of the extracts of
leeches, earthworms, salvia, paeonol, turmeric root tu-
ber, and pinellia at a ratio of 3:3:3:3:3:2 by mass. Simv-
astatin (commercial name, zocor) was purchased from
Merck Sharp & Dohme (Whitehouse Station, NJ,
USA; production series number 2009014). By scaling
down the recommended daily dosage for adult humans
to the body weight of rabbits[9], we determined that the
mid-dose of Wenxiao II Decoction for rabbits should
be 575 mg/kg/d of the extracts of leeches, earthworms,
salvia, paeonol and turmeric root tuber, and to 383.33
mg/kg/d of pinellia extract. We established the ratio of
high:medium:low doses at 4:2:1. The daily dose for
rabbits in the simvastatin group was 0.77 mg/kg/d.
Animal feed
A high-cholesterol diet (1% cholesterol, 5% egg yolk
powder, and 3% lard mixed with 91% standard feed)
was prepared by the Experimental Animal Center of
the Sixth People's Hospital of Shanghai.
Reagents and instruments
Balloon catheters (2.5 mm × 10 mm) were purchased
from Cordis Corporation (Bridgewater, NJ, USA). Di-
aminobenzidine Color Kits were purchased from Sigma
–Aldrich (St Louis, MO, USA). Anti-rabbit VCAM-1
monoclonal antibody was purchased from Boster Bio-
logical Technology (Fremont, CA, USA). MCP-1 (1:
250 dilution) was purchased from Santa Cruz Biotech-
nology (Santa Cruz, CA, USA). Optical microscope
was purchased from Olympus Scientific Equipment
Group (Tokyo, Japan). Medical analysis software and
IMS Cell Image Analysis Systems were purchased from
Shanghai Shenteng Information Technology Co., Ltd.
(Shanghai, China).
Modeling and grouping
After being fed a standard diet (150 g/d) for 7 days, no
abnormalities were observed in any experimental rab-
bits. Animals were randomly divided into a blank
group (10 rabbits) and a model group (50 rabbits).
Both groups had free access to water. The blank group
continued with the 150 g/d standard diet, and the
model group was fed 100 g/d of a high-cholesterol diet
and 50 g/d of the standard diet. One week later, all rab-
bits underwent balloon-induced injury to the endothe-
lium of the carotid artery[10-13], and continued to feed
on the high-cholesterol diet until the end of the eighth
week. Two rabbits were randomly selected and killed,
and their internal carotid arteries collected 1-2-cm dis-
tal from the bifurcation of the internal and external ca-
rotid arteries. These specimens were made into paraffin
sections for observation under a light microscope. This
procedure confirmed that there were different degrees
of atherosclerosis on the walls of the carotid arteries:
the atherosclerosis model had been established.
After the establishment of the atherosclerosis model,
the 10 rabbits in the blank group survived, and 7 rab-
bits in the model group died. One died due to an anes-
thetic accident, 2 of surgical bleeding, 1 of postopera-
tive infection, one of diarrhea-related complications, 2
of unknown causes, and 2 were killed to confirm the es-
tablishment of the model.
Thereafter, the atherogenic diet was replaced with a reg-
ular diet. The remaining 41 rabbits were randomly di-
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vided into five groups for treatment: high dose (n=8),
moderate dose (n=8), and low dose (n=8) of Wenxiao
II Decoction; simvastatin (n=8); and control (n=9).
Drug administration and specimen collection
The three dosage groups and simvastatin group were
given the drugs to be tested. Drugs were dissolved in
distilled water, mixed, and then administered via the in-
tragastric route each day. The blank group was given
equal volumes of physiological (0.9%) saline solution.
Each group was fed the standard diet, and had free ac-
cess to water, during these 8 weeks.
At the end of the eighth week after the implementation
of drug intervention, all animals were deprived of food
and water for 12 h, and then anaesthetized with pento-
barbital sodium (1.1-1.3 mL/kg). Blood samples were
collected and the serum centrifuged with 3000 rpm for
15 min at room temperature. Rabbits were killed un-
der sterile conditions so that their internal carotid arter-
ies could be extracted 1-2 cm distal from the bifurca-
tion of the internal and external carotid arteries. Oph-
thalmic scissors were used to cut along the long axis of
the carotid arteries, where white or light-yellow fatty
streaks and plaques could be seen with the naked eye.
Specimens were gently rinsed with 0.9% saline solu-
tion and placed in 4% neutral formaldehyde solution
for fixation. They were preserved at–40°C.
Staining and imaging
MCP-1 and VCAM-1 were detected by immunohisto-
chemical staining. Experimental procedures were strict-
ly in accordance with the manufacturers,instructions
enclosed with the kits. One section was randomly se-
lected from each specimen and observed under × 250
magnification under an optical microscope (Olympus
BX51), purchased from Olympus Scientific Equip-
ment Group (Tokyo, Japan). Five views were taken,
and IMS Cell Image Analysis software used to calculate
the ratio of positive expression area to total area (%).
Statistical analyses
Data were analyzed with the statistical software pack-
age SPSS 11.5 (SPSS, Chicago, IL, USA). Measure-
ment data are the mean±standard deviation. The statis-
tical significance of differences between groups of data
was tested by One-way ANOVA. All P values are
two-sided. P<0.05 was considered significant.
RESULTS
General health status
During the intervention phase, 1 rabbit from the
mid-dose group died of pneumonia, 1 from the model
group died of gangrene necrosis, 1 from the blank died
of diarrhea-related complications, and 1 in the simvas-
tatin group died of an unidentified cause.
Comparison of the expression of MCP-1 and
VCAM-1 among groups after intervention
The expression of MCP-1 and VCAM-1 for all three
dosages of Wenxiao II Decoction and for simvastatin
was significantly decreased compared with that seen in
the model group (P<0.05). When compared with the
simvastatin group, the expression of MCP-1 in the
low-dose Wenxiao II Decoction group was significantly
increased (P<0.05). However, there were no significant
differences among the simvastatin group and medium-
or high-dose groups of Wenxiao II Decoction with re-
gard to MCP-1, or in the three dosages of the Wenxiao
II Decoction groups with respect to VCAM-1 (P>
0.05). The expression of MCP-1 in the mid- and
high-dose Wenxiao II Decoction groups was lower
than that in the low-dose Wenxiao II Decoction group
(P<0.05). VCAM-1 expression in the mid- and
high-dose Wenxiao II Decoction groups was lower
than that in the low-dose group, but this difference
was not significant (P>0.05) (Table 1 and Figures A-L).
Table 1 Comparison of the expression of MCP-1 and VCAM-1
( xˉ ±s)
Group
High dose
Mid dose
Low dose
Simvastatin
Model control
N
8
7
8
7
8
MCP-1 (%)
2.68±0.30*▲
2.98±0.28*▲
3.89±0.59*△
2.66±0.34*
4.83±0.54
VCAM-1 (%)
2.72±0.55*
2.88±0.55*
3.28±0.57*
2.68±0.61*
5.03±0.88
Notes: Compared with the model group, *P<0.05; compared
with the simvastatin group,△P<0.05; compared with the
low-dose Wenxiao II Decoction group,▲P<0.05.
DISCUSSION
The Wenxiao II Decoction comprises extracts of leech-
es, earthworms, salvia, paeonol, turmeric root-tuber,
and pinellia. According to TCM, the leech extract is
the "king of medicines"; it can break up dead and coag-
ulated blood in the body. ZHANG Zhong-jing said
"Most of the blood-breaking medicines work at the Qi
level. Only the salty leech can go deep into blood with-
out damaging the Qi; it can break up blood impercepti-
bly. It is a truly good medicine." Earthworm extracts
can invigorate blood circulation. They are very mobile
and can reach many parts of the body through the me-
ridians. They are considered to be primary medicines.
Extracts of salvia and paeonol are believed to cool the
blood, invigorate the blood circulation, break up dead
blood cells, and expel heat and toxins from the blood.
They are considered to be auxiliary medicines. Pinellia
can expel dampness and phlegm as well as diminish the
aggregation of pathogenic materials in the body. The
fast pace and competitive pressures of modern life can
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easily render liver Qi stagnant. This stagnant liver Qi
tends to“fire up”if not soothed. Enflamed Qi can
readily burn away Yin fluid, causing the blood to be-
come viscous and stagnate. Extracts of turmeric root tu-
bers can soothe the liver Qi and stimulate blood circu-
lation while simultaneously cooling inflamed blood.
According to TCM, the combination of these compo-
nents causes the Wenxiao II Decoction to stabilize and
diminish plaques by stimulating blood circulation,
soothing liver Qi, dispelling heat, and reducing stag-
nancy.
Atherosclerosis is the common pathological basis of car-
dio-cerebrovascular diseases. Ross stated that atheroscle-
rosis is an inflammatory disease[1]. It has the pathologi-
cal characteristics of a chronic inflammatory process,
and its development is associated with inflammatory re-
sponses. Research shows that the main monocyte che-
moattractant in this process is MCP-1[14]. MCP-1
binds to chemokine receptor-2, activating the mito-
gen-activated kinase cascade. Mononuclear cells in the
blood then migrate to the space beneath the endotheli-
um and become activated as macrophages. These mac-
rophages phagocytize lipids and form foam cells.
MCP-1 also stimulates the production of other cyto-
kines (e.g., TNF-α, interleukin-1 (IL-1), IL-6) and the
activation of matrix metalloproteinases[15]. This leads to
the development of atherosclerosis, plaque instability,
as well as acute cardiovascular and cerebrovascular
events. Hence, some scholars believe that MCP-1 can
be used as a non-invasive means of detecting the degree
of plaque inflammation[16]. The level of MCP-1 increas-
es with the progression of atherosclerosis, so the plasma
Figure A-L: A brown color indicates positive expression. The model group had the most intense color, and the expression of
VCAM-1 in the high dose of Wenxiao II Decoction group and simvastatin group was the weakest. High-dose group (Figure A and
Figure G); mid-dose group (Figure B and Figure H); low-dose group (Figure C and Figure I); simvastatin group (Figure D and Figure
J); model group (Figure E and Figure K); blank group (Figure F and Figure L).
A B C
D E F
G H I
J K L
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level of MCP-1 may be useful for evaluating the effica-
cy of treatments for atherosclerosis[17,18].
VCAM-1 belongs to the immunoglobulin supergene
family, and is mainly expressed in activated endothelial
cells, monocytes, and epithelial cells. The expression of
VCAM-1 aggravates vascular endothelial injury at the
start of atherosclerosis[19]. As atherosclerosis progresses,
it mainly promotes monocyte movement and T-lym-
phocyte activation, which infiltrate into the nidus.
This promotes interactions among cells and promotes
infiltration of monocytes into the subendothelium.
These actions transform monocytes into macrophages,
who phagocytose lipids and form foam cells. On the
one hand, VCAM-1 provides lymphocyte interactions
with antigens and triggers local immune responses. On
the other hand, VCAM-1 releases various cytokines
which may cause the transformation and proliferation
of vascular smooth muscle cells, which gradually form
fibrous plaques[20,21] and eventually impact to the stabili-
ty of atherosclerotic plaques.
Statins are regarded to be the most effective plaque-sta-
bilizing drugs available. We found that the expression
of MCP-1 and VCAM-1 decreased in the simvastatin
group as well as in the three Wenxiao II Decoction dos-
age groups (P<0.05) compared with the model group.
Further statistical analyses showed that the expression
of MCP-1 and VCAM-1 in the three Wenxiao II De-
coction dosage groups was higher compared with that
seen in the simvastatin group, but no significant differ-
ences were found except for MCP-1 in the low-dose
Wenxiao II Decoction group (P<0.05). Comparison
with the three dosage groups revealed that high- and
mid-doses of Wenxiao II Decoction could more signifi-
cantly decrease MCP-1 expression, and no other differ-
ences were found. These findings suggest that Wenxiao
II Decoction may stabilize atherosclerotic plaques at all
doses.
The present study suggested that Wenxiao II Decoc-
tion can invigorate the blood circulation, soothe Qi,
clean-up blood vessels, and expel phlegm and heat in
the body. However, inhibition of the expression of in-
flammatory cytokines may be the relevant mechanism
underlying its efficacy in the treatment of atherosclero-
sis.
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